Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 6,080 shares at $20.11 ($123K) on 2024-02-20, disclosed to the SEC on 2024-02-22.
Scheduled sale ($123k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.11 | 2,591 | $52K | 42.5% |
| 2 | $20.11 | 2,591 | $52K | 42.5% |
| 3 | $20.58 | 898 | $18K | 15.1% |
| Total | $20.18 avg | 6,080 | $123K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-19 | $172K | — | Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |